Synthesis, characterization, and in silico studies of 1,8-naphthyridine derivatives as potential anti-Parkinson’s agents

References

• Ahmed, M., & Kelley, S. O. (2017). Enhancing the potency of nalidixic acid toward a bacterial DNA gyrase with conjugated peptides. ACS Chemical Biology, 12(10), 2563–2569. https://doi.org/10.1021/acschembio.7b00540
   PubMed Web of Science ®Google Scholar
• Azam, F., Ibn-Rajab, I. A., & Alruiad, A. A. (2009). Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure-activity relationships. Die Pharmazie, 64(12), 771–795.
   PubMed Web of Science ®Google Scholar
• Ball, P. (2000). Quinolone generations: Natural history or natural selection? Journal of Antimicrobial Chemotherapy, 46(Suppl 3), 17–24. https://doi.org/10.1093/oxfordjournals.jac.a020889
   PubMedGoogle Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1-3), 43–56. https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Diaz, N. L., & Waters, C. H. (2009). Current strategies in the treatment of Parkinson's disease and a personalized approach to management. Expert Review of Neurotherapeutics, 9(12), 1781–1789. https://doi.org/10.1586/ern.09.117
   PubMed Web of Science ®Google Scholar
• Ellis, J. M., & Fell, M. J. (2017). Current approaches to the treatment of Parkinson's disease. Bioorganic & Medicinal Chemistry Letters, 27(18), 4247–4255. https://doi.org/10.1016/j.bmcl.2017.07.075
   PubMed Web of Science ®Google Scholar
• Fox, S. H., Katzenschlager, R., Lim, S.-Y., Barton, B., de Bie, R. M. A., Seppi, K., Coelho, M., & Sampaio, C., Movement Disorder Society Evidence-Based Medicine Committee. (2018). International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society, 33(8), 1248–1266. https://doi.org/10.1002/mds.27372
   PubMed Web of Science ®Google Scholar
• Gurjar, V. K., & Pal, D. (2019). Recent developments and multiple biological activities available with 1,8-naphthyridine derivatives: A review. International Journal of Pharmacy and Pharmaceutical Sciences, 11(1), 17–37. https://doi.org/10.22159/ijpps.2019v11i1.30429
   Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins, 55(2), 351–367. https://doi.org/10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Kannappan, R., Gupta, S. C., Kim, J. H., Reuter, S., & Aggarwal, B. B. (2011). Neuroprotection by spice-derived nutraceuticals: You are what you eat! In Molecular neurobiology. Humana Press Inc. https://doi.org/10.1007/s12035-011-8168-2
   Google Scholar
• Kumar, A., Agarwal, P., Rathi, E., & Kini, S. G. (2020). Computer-aided identification of human carbonic anhydrase isoenzyme VII inhibitors as potential antiepileptic agents. Journal of Biomolecular Structure and Dynamics, 40, 1–16. https://doi.org/10.1080/07391102.2020.1862706
   PubMed Web of Science ®Google Scholar
• Lin, X. M., Li, H., Wang, C., & Peng, X. X. (2008). Proteomic analysis of nalidixic acid resistance in Escherichia coli: Identification and functional characterization of om proteins. Journal of Proteome Research, 7(6), 2399–2405. https://doi.org/10.1021/pr800073c
   PubMed Web of Science ®Google Scholar
• Madaan, A., Verma, R., Kumar, V., Singh, A. T., Jain, S. K., & Jaggi, M. (2015). 1,8-Naphthyridine derivatives: A review of multiple biological activities. Archiv Der Pharmazie, 348(12), 837–860. https://doi.org/10.1002/ardp.201500237
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• McFarthing, K., Buff, S., Rafaloff, G., Dominey, T., Wyse, R. K., & Stott, S. R. W. (2020). Parkinson's disease drug therapies in the clinical trial pipeline: 2020. Journal of Parkinson's Disease, 10(3), 757–774. https://doi.org/10.3233/JPD-202128
   PubMedGoogle Scholar
• Moustafa, A. A., Chakravarthy, S., Phillips, J. R., Gupta, A., Keri, S., Polner, B., Frank, M. J., & Jahanshahi, M. (2016). September 1). Motor symptoms in Parkinson's disease: A unified framework. Neuroscience and Biobehavioral Reviews, 68, 727–740. https://doi.org/10.1016/j.neubiorev.2016.07.010
   PubMed Web of Science ®Google Scholar
• Munchau, A., & Bhatia, K. P. (2000). Pharmacological treatment of Parkinson's disease. Postgraduate Medical Journal, 76(900), 602–610. https://doi.org/10.1136/pmj.76.900.602
   PubMed Web of Science ®Google Scholar
• Ojha, M., Yadav, D., Kumar, A., Dasgupta, S., & Yadav, R. (2021). 1,8-Naphthyridine derivatives: A privileged scaffold for versatile biological activities. Mini Reviews in Medicinal Chemistry, 21(5), 586–601. https://doi.org/10.2174/1389557520666201009162804
   PubMed Web of Science ®Google Scholar
• Pinna, A., Wardas, J., Simola, N., & Morelli, M. (2005). November 12). New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists. Life Sciences, 77(26), 3259–3267. https://doi.org/10.1016/j.lfs.2005.04.029
   PubMed Web of Science ®Google Scholar
• Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014). The prevalence of Parkinson’s disease: A systematic review and meta-analysis. Movement Disorders, 29(13), 1583–1590. https://doi.org/10.1002/mds.25945
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Richardson, C. M., Gillespie, R. J., Williamson, D. S., Jordan, A. M., Fink, A., Knight, A. R., Sellwood, D. M., & Misra, A. (2006). Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches. Bioorganic & Medicinal Chemistry Letters, 16(23), 5993–5997. https://doi.org/10.1016/j.bmcl.2006.08.116
   PubMed Web of Science ®Google Scholar
• Rizek, P., Kumar, N., & Jog, M. S. (2016). An update on the diagnosis and treatment of Parkinson disease. CMAJ : Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne, 188(16), 1157–1165. https://doi.org/10.1503/cmaj.151179
   PubMed Web of Science ®Google Scholar
• Sankhe, R., Rathi, E., Manandhar, S., Kumar, A., Pai, S. R. K., Kini, S. G., & Kishore, A. (2021). Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study. Journal of Molecular Structure, 1224, 129073. https://doi.org/10.1016/j.molstruc.2020.129073
   PubMed Web of Science ®Google Scholar
• Schapira, A. H. V. (2009). Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci, 30(1), 41–47. https://doi.org/10.1016/j.tips.2008.10.005
   PubMed Web of Science ®Google Scholar
• Tysnes, O. B., & Storstein, A. (2017). Epidemiology of Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996), 124(8), 901–905. https://doi.org/10.1007/s00702-017-1686-y
   PubMed Web of Science ®Google Scholar
• Vizza, P., Tradigo, G., Mirarchi, D., Bossio, R. B., Lombardo, N., Arabia, G., Quattrone, A., & Veltri, P. (2019). Methodologies of speech analysis for neurodegenerative diseases evaluation. International Journal of Medical Informatics, 122, 45–54. https://doi.org/10.1016/j.ijmedinf.2018.11.008
   PubMed Web of Science ®Google Scholar
• Winiarska-Mieczan, A., Baranowska-Wójcik, E., Kwiecień, M., Grela, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020). The role of dietary antioxidants in the pathogenesis of neurodegenerative diseases and their impact on cerebral oxidoreductive balance. Nutrients, 12(2), 435. https://doi.org/10.3390/nu12020435
   PubMed Web of Science ®Google Scholar